Company / Current Assets
Zenas BioPharma, Inc. Current Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$351.2M
FY2025
5-year range
$59.8M / $355.9M
FY2023-FY2025
Trend
-1.3%
vs FY2024
Sector context
#147 of 213
Health Care
What the data says
At $351M, Zenas BioPharma, Inc.'s current assets ranks #147 of 213 in the Health Care sector. Improved from $60M to $351M over the past 2 years.
Based on SEC 10-K filings.
$351M in FY2025.
Improved from $60M to $351M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#147 of 213 in Health CareTop 69% of 213This company $351.2M Sector average $2.5B
▼
-86.1% below sector average
Key checks
Key Insights
- In FY2025, current assets decreased 1.3% year-over-year.
- Ranks #147 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $351.2M | -1.3% |
| FY2024 | $355.9M | +495.1% |
| FY2023 | $59.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026